Post-Lyme disease syndrome under trial.
O'Brien
C
C
D000954:Antigens, Surface / Q000276:immunology; D001168:Arthritis; D001425:Bacterial Outer Membrane Proteins / Q000276:immunology; D001428:Bacterial Vaccines; D015748:Borrelia burgdorferi Group / Q000378:metabolism*; D002443:Ceftriaxone / Q000627:therapeutic use; D006801:Humans; D008074:Lipoproteins; D008193:Lyme Disease / Q000150:complications* / Q000503:physiopathology / Q000628:therapy; D014481:United States; D014611:Vaccination
D000954:Antigens, Surface; D001425:Bacterial Outer Membrane Proteins; D001428:Bacterial Vaccines; D008074:Lipoproteins; C072045:OspA protein; D002443:Ceftriaxone